Deal Watch: Auxilium Accepts Endo Buyout Rather Than Completing Purchase Of QLT Shell

Actavis continues filling out its portfolio by acquiring Durata, but leaves room for other transformational deals. Impax moves strongly into generics and adds an FDA-licensed manufacturing site in buying three companies under the Tower Holdings umbrella.